Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us

Profile

Hideki Hasegawa

HH

Hideki Hasegawa

Talk Title: Induction and Functional Characterization of Secretory IgA by Intranasal Inactivated Influenza Vaccination

National Institute of Infectious Diseases, Japan

Talk Title: Induction and Functional Characterization of Secretory IgA by Intranasal Inactivated Influenza Vaccination

Dr. Hideki Hasegawa, M.D., Ph.D., is Director of the Influenza Research Center and WHO Collaborating Centre at NIID, Japan Institute for Health Security. A virologist and pathologist, he focuses on emerging infectious diseases, mucosal immunology, and influenza vaccines. He has characterized pandemic and avian influenza pathology, investigated SFTS, and advanced intranasal inactivated influenza vaccine development. His work on secretory IgA has contributed to mucosal vaccine strategies, including a COVID-19 recombinant protein vaccine. Dr. Hasegawa earned his degrees from Hokkaido University and completed postdoctoral training at The Rockefeller University and University College Dublin.